Cryoport, Inc. (CYRX) CEO Jerrell Shelton on Q2 2022 Results – Earnings Call Transcript

Saturday, 6 August 2022, 16:38:04
Cryoport, Inc. (NASDAQ:NASDAQ:CYRX) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Todd Fromer – Managing Partner-KCSA Jerrell Shelton – Chief Executive…
— Seeking Alpha

Cryoport Reports Results for the Second Quarter 2022

Thursday, 4 August 2022, 22:05:00
Record revenue of $64.2 million for the quarter, up 14% as reported and 18% at constant currency (year-over-year) Supporting a record 626 global clinical trials; a net of 17 new trials added during the quarter Opened first two Global Supply Chain Centers, which include BioServices, in…
— PR Newswire

Cryoport: Rapid Growth Is Great, But Shares Look Overpriced (NASDAQ:CYRX)

Saturday, 30 July 2022, 05:13:50
Cryoport has done well to grow its top line in recent years and some bottom line figures have also fared well. Read why I rate CYRX a ‘sell’ for now.
— Seeking Alpha

Cryoport Inc. (NASDAQ: CYRX) Recovered 24.41% From The 52-Week Low, And Now It’s -55.69% YTD – This Is What You Do Now

Saturday, 28 May 2022, 16:30:00
Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting 1.25. At the close of trading, the stock’s price was $26.22, to imply an increase of 13.56% or $3.13 in intraday trading. The CYRX share’s 52-week high remains $86.30, putting it -229.14% down since that peak … Cryoport Inc. (NASDAQ: CYRX) Recovered 24.41% From The 52-Week Low, And Now It’s -55.69% YTD – This Is What You Do Now Read More »
— Marketing Sentinel

Cryoport Stock: To Resume Aggressive Growth (NASDAQ:CYRX)

Wednesday, 11 May 2022, 21:18:58
Cryoport is not just any biotech company, as it is banking on the booming logistic businesses for the cell/gene therapy sector. Read more about CYRX here.
— Seeking Alpha